Skip to main content
SpringerLink
Log in

Initiative to lower drug costs sparks controversy in Switzerland

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Initiative to lower drug costs sparks controversy in Switzerland. Pharmacoecon. Outcomes News 301, 11 (2001). https://doi.org/10.1007/BF03269195

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03269195

Keywords

Search

Navigation